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The Mechanism of Hsp90 Regulation by
the Protein Kinase-Specific Cochaperone p50cdc37
opening and closing of a “molecular clamp” via transient
ATP-dependent association of the N-terminal domains
in the Hsp90 dimer (Prodromou et al., 2000; Chadli et
S. Mark Roe,1,4 Maruf M. U. Ali,1,4 Philippe Meyer,1,5
Cara K. Vaughan,1 Barry Panaretou,2 Peter W. Piper,3,6
Chrisostomos Prodromou,1,* and Laurence H. Pearl1,*
al., 2000). Small molecules such as geldanamycin and1Section of Structural Biology
radicicol, which are competitive inhibitors of ATP bind-The Institute of Cancer Research
ing to the N-terminal nucleotide binding domain, (Steb-Chester Beatty Laboratories
bins et al., 1997; Prodromou et al., 1997a; Roe et al.,237 Fulham Road
1999), prevent closure of the clamp and disrupt clientLondon SW3 6JB
protein activation (Whitesell et al., 1994; Schulte et al.,United Kingdom
1995; Chavany et al., 1996).2 Division of Life Sciences
The largest coherent class of proteins amongstKing’s College London
Hsp90s structurally and functionally varied clientele areFranklin-Wilkins Building
the protein kinases. Known protein kinase clients in150 Stamford Street
mammalian cells include: PKB/Akt (Sato et al., 2000;London SE1 9NN
Basso et al., 2002; Fontana et al., 2002), PDK1 (FujitaUnited Kingdom
et al., 2002), LKB1 (Boudeau et al., 2003), Raf-1 (Stan-3 Department of Biochemistry and Molecular Biology
cato et al., 1993; Schulte et al., 1995; Grammatikakis etUniversity College London
al., 1999), ErbB2 (Xu et al., 2001), Bcr-Abl (An et al.,Gower Street
2000), Src-family kinases (Xu and Lindquist, 1993; Xu etLondon WC1E 6BT
al., 1999; Bijlmakers and Marsh, 2000), Aurora B (LangeUnited Kingdom
et al., 2002), and the cyclin-dependent kinases Cdk4,
Cdk6, and Cdk9 (Stepanova et al., 1996; Mahony et al.,
1998; O’Keeffe et al., 2000). The involvement of Hsp90Summary
in the activity of so many potentially oncogenic protein
kinases has engendered considerable interest in Hsp90Recruitment of protein kinase clients to the Hsp90
as a target for cancer chemotherapy (reviewed in Neck-chaperone involves the cochaperone p50cdc37 acting as
ers, 2002; Maloney and Workman, 2002; Blagosklonny,a scaffold, binding protein kinases via its N-terminal
2002).domain and Hsp90 via its C-terminal region. p50cdc37
Activation of Hsp90-dependent client proteins pro-also has a regulatory activity, arresting Hsp90’s ATP-
ceeds through an ordered sequence of complexes,ase cycle during client-protein loading. We have local-
linked to the ATPase cycle, and involving a variety ofized the binding site for p50cdc37 to the N-terminal nucle-
cochaperones (reviewed in Pearl and Prodromou, 2002).otide binding domain of Hsp90 and determined the
Hsp90-dependent protein kinases in mammalian cellscrystal structure of the Hsp90–p50cdc37 core complex.
are particularly associated with a 50 kDa proteinDimeric p50cdc37 binds to surfaces of the Hsp90
(Brugge, 1986), whose N-terminal region has strong ho-N-domain implicated in ATP-dependent N-terminal di-
mology to the equivalent region of Cdc37p from buddingmerization and association with the middle segment
yeast (Perdew et al., 1997; Stepanova et al., 1996). Func-of the chaperone. This interaction fixes the lid segment
tional dissection of this protein, p50cdc37, identified a pro-in an open conformation, inserts an arginine side chain
tein kinase binding domain at the N terminus (Grammati-into the ATP binding pocket to disable catalysis, and
kakis et al., 1999), while the remainder of the proteinprevents trans-activating interaction of the N domains.
was found to interact with Hsp90 (Shao et al., 2001).
Thus, p50cdc37 acts as an adaptor or scaffold, facilitating
Introduction protein kinase interaction with the Hsp90 molecular
chaperone (Silverstein et al., 1998). Binding to p50cdc37
Hsp90 is a molecular chaperone with an essential role is highly specific, and otherwise closely related protein
in eukaryotes in activation and maintenance of a wide kinases may differ substantially in their interaction. Thus,
range of regulatory and signaling proteins (Pearl and Cdk4 associates with p50cdc37, whereas Cdk2 does not
Prodromou, 2002; Picard, 2002; Pratt and Toft, 2003). (Dai et al., 1996; Stepanova et al., 1996). Similarly, the
Client protein activation by Hsp90 requires its ATPase MAP-kinase MOK binds p50cdc37, while ERK, JNK, and
activity (Panaretou et al., 1998; Obermann et al., 1998), p38 do not (Miyata et al., 2001). While the majority of
which is coupled to a conformational cycle involving Hsp90-dependent protein kinases so far identified are
also dependent on p50cdc37 (Hunter and Poon, 1997), the
converse may not always be true and for some kinases*Correspondence: laurence.pearl@icr.ac.uk (L.H.P.), chris.prodromou
@icr.ac.uk (C.P) interaction with p50cdc37 alone may be sufficient to afford
4These authors contributed equally to this work. a degree of stabilization (Tatebe and Shiozaki, 2003; Lee
5Present address: Laboratoire d’Enzymologie et de Biochimie et al., 2002).
Structurales, CNRS, Avenue de la Terrasse, 91198 Gif sur Yvette,
We have previously shown that p50cdc37 is not a passiveFrance.
scaffold, but is an active Hsp90 cochaperone participat-6Present address: Department of Molecular Biology and Biotechnol-
ing in regulation of the Hsp90 chaperone cycle (Siligardiogy, The University of Sheffield, Firth Court, Western Bank, Sheffield
S10 2TN, United Kingdom. et al., 2002). Thus, like the TPR-domain cochaperone
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Hop/Sti1 (Prodromou et al., 1999; Richter et al., 2003), known structure of the yeast Hsp90 N-terminal domain
(N-Hsp90) (Prodromou et al., 1997a, 1997b) as a searchp50cdc37 is able to arrest the ATPase cycle to facilitate
client protein loading. This property resides in the C-ter- model. The structure of C-p50cdc37 was determined from
difference Fourier maps and the structure of the com-minal part of the molecule and is retained, although to
a lesser degree, in the yeast Cdc37p, whose C terminus plex refined at 2.4 A˚ (see Experimental Procedures).
has only low homology to its mammalian homologs. In
order to define the nature of the functional interaction Structure of C-p50cdc37
between p50cdc37 and Hsp90, we have mapped the The C-terminal segment of p50cdc37 is entirely helical in
p50cdc37 binding region in Hsp90 to the N-terminal nucle- structure, consisting of a large 6-helix bundle at the
otide binding domain and determined the crystal struc- N-terminal end of the visible structure (residues 148–
ture of the core Hsp90-p50cdc37 complex. The structure 245) connected to a small 3-helix bundle (292–347) via
reveals the mechanism by which p50cdc37 arrests the a long single helix (246–286). This small helical bundle
ATPase cycle of Hsp90, locking the “lid” of the nucleo- is less well ordered than the rest of C-p50cdc37 and no
tide binding pocket in an open conformation, and hold- interpretable electron density is present for residues
ing the “jaws” of the Hsp90 molecular clamp apart to 309–315, which connect the first and second helices of
facilitate client protein loading. this domain. The large helical domain has an unusual
topology, with helices 2–5 forming a right-handed or-
thogonal 4-helix bundle, while helix 6 and the proximalResults and Discussion
part of the long connecting helix form an -arch that
wraps around the surface of helix 5 (Figure 2A). Compari-Localizing the Hsp90-p50cdc37 Interaction
son of C-p50cdc37 with libraries of known protein foldsPrevious studies of cochaperone interactions with
yielded no structure of comparable topology (Pearl etHsp90 had shown mutually exclusive binding of p50cdc37
al., 2000; Murzin et al., 1995). The sequence of this regionand TPR-domain cochaperones such as Hop/Sti1 (Ow-
is reasonably conserved in vertebrates becoming moreens-Grillo et al., 1996), which has been generally inter-
diverged in invertebrates and fungi (Figure 2B). Nonethe-preted in terms of competitive binding by p50cdc37 at or
less, optimal sequence threading (Jones et al., 1992)close to the known TPR binding site at the C terminus
of the highly diverged S. cerevisiae Cdc37p sequenceof Hsp90. However, there was some ambiguity in this
unambiguously recognizes the large globular domain ofassignment, as although p50cdc37 binding was competed
p50cdc37 as the best fit, suggesting that despite sequenceby full-length TPR-domain cochaperones, an isolated
variation the overall fold is universally conserved.TPR-domain could bind simultaneously with p50cdc37 (Sil-
In the crystals, C-p50cdc37 forms a homodimeric inter-verstein et al., 1998). To resolve this question, we ana-
action with a symmetry related molecule (Figures 3A,lyzed the interaction between p50cdc37 or a C-terminal
3B, and 3C). The core of the interface involves closesegment of p50cdc37 (C-p50cdc37: residues 138–378) pre-
packing of the main chain and side chains of Gln 247viously shown to be sufficient for Hsp90 binding (Shao
and Tyr 248, in the first turn of the long connectinget al., 2001; Siligardi et al., 2002), and a set of yeast
helix, with their equivalents in the other monomer. ThisHsp90 constructs, using isothermal titration calorimetry
hydrophobic core interaction is reinforced by ion-pairs(ITC) (Figure 1). As expected from previous studies using
between Lys 240 and Asp 245 from separate monomers,difference CD (Siligardi et al., 2002), full-length p50cdc37
a carboxyl-carboxylate interaction between the sideand C-p50cdc37 bound to full-length Hsp90 with very simi-
chains of Asp 294 from each monomer, and a networklar affinities (Kd  1.46 M, and 1.32 M, respectively).
of hydrogen bonding involving the side chains of ArgHowever, no significant heats of interaction were ob-
246 and Glu 250 from one monomer with Glu 221 andserved with any Hsp90 construct lacking the N-terminal
Glu 255 from the other (Figure 3D). Previous studiesnucleotide binding domain, regardless of the presence
showed that full-length p50cdc37 is a dimer in solutionor absence of the C-terminal constitutive dimerization
with a Kd 5–10 M (Siligardi et al., 2002). The isolateddomain. Consistent with these observations the isolated
C-terminal domain of p50cdc37 retains the ability to dimer-nucleotide binding domain bound to C-p50cdc37 with com-
ize but with reduced affinity (Kd  170 M). However,parable affinity to full-length Hsp90 (Kd  1.80 M),
at the concentrations used in crystallization experimentsidentifying it unambiguously as the primary binding site
and in the presence of the molecular crowding agentsfor p50cdc37. Although Hsp90s are extremely highly con-
used to promote crystallization, C-p50cdc37 would be pre-served especially in the N-terminal domain, we were
dominantly dimeric so that the dimer observed in theconcerned to verify that this interaction was not an arti-
crystals is likely to be authentic. The relatively smallfact of yeast Hsp90 binding to human p50cdc37. In confir-
surface area buried in that interface (560 A˚2) would bemation of this, we found that the N-terminal domain of
consistent with the measured affinity.human Hsp90 bound to C-p50cdc37 with comparable
affinity (Kd  3.37 M). In all cases, p50cdc37 constructs
and Hsp90 constructs formed complexes with 1:1 stoi- Hsp90-p50cdc37 Interactions
The Hsp90 N-terminal nucleotide binding domain bindschiometry.
On the basis of this observation, crystallization screens to the large helical domain of C-p50cdc37, with helices 2,
3, and 5 from C-p50cdc37 packing against the surface ofwere conducted with equimolar mixtures of C-p50cdc37 and
various Hsp90 N-terminal domain constructs. Diffraction the lid segment in N-Hsp90 (residues 100–121), which
is thought to close over bound ATP (Prodromou et al.,quality crystals were obtained in several conditions us-
ing human C-p50cdc37 and yeast Hsp90(1–208). The struc- 2000) (Figure 4A). The core of the interaction involves
a relatively flat hydrophobic patch formed by the sideture was phased by molecular replacement using the
Structure of Hsp90-p50cdc37 Complex
89
Figure 1. Localization of Hsp90-C-p50 Inter-
action
(A) Schematic of the domain structure of
p50cdc37 (left) and Hsp90 (right)
(B) Isothermal titration calorimetry (ITC) of
full-length human p50cdc37 injected into full-
length yeast Hsp90. The proteins interact with
Kd  1.46 M, with 1:1 stoichiometry, con-
sistent with previous observations (Siligardi
et al., 2002).
(C) ITC of a C-terminal construct of p50cdc37
(residues 138–378: C-p50cdc37) binding to full-
length yeast Hsp90. The affinity of the interac-
tion is very similar to that of the full-length pro-
teins, confirming the previous observation that
Hsp90 binding was a function of C-p50cdc37.
(D) ITC of C-p50cdc37 binding to the isolated
nucleotide binding domain of Hsp90 (1–220:
N-Hsp90). The affinity of the interaction is
very close to that of the full-length protein,
identifying N-Hsp90 as the primary binding
site for p50cdc37.
(E) As (D), but with the N-terminal nucleotide
binding domain of human Hsp90 which has
69% sequence identity to the yeast equivalent.
The similar affinity demonstrates unequivocally
that the interaction between C-p50cdc37 and
N-Hsp90 is authentic and universal.
chains of Met 164, Leu 165, Ala 204, and Leu 205 of closure and N-terminal association on binding of ATP
(Prodromou et al., 2000). As Ala 107 is intimately involvedp50cdc37, which pack against a similar patch formed by
the side chains of Ala 103, Ala 107, Ala110, Gly 111, in the close-packed hydrophobic interface with p50cdc37
observed in these crystals, its mutation to a larger hydro-Ala 112, Met 116, and Phe 120 of Hsp90. The central
hydrophobic interface is reinforced by a network of polar philic residue would be expected to have a very substan-
tial impact if that is indeed the functional interface be-interactions including several intermolecular side chain
to main chain hydrogen bonds. The most substantial tween the two proteins. We therefore analyzed the effect
of the A107N mutation on interaction of Hsp90 withpart of this network involves Gln 119 of Hsp90 whose
main chain oxygen is hydrogen bonded to the side chain p50cdc37 in solution. In marked contrast to the wild-type,
the ATPase activity of the Hsp90-A107N mutant wasof Gln 208 of p50cdc37, while its side chain hydrogen
bonds to the main chain carbonyl of Asp 120 and the completely resistant to inhibition by p50cdc37 (Figure 4C).
We also examined the sensitivity of a second Hsp90main chain nitrogens of Arg 166 and Arg 167 of p50cdc37
(Figure 4B). The interaction of Hsp90 and p50cdc37 buries mutant, T22I, which like A107N has a substantially en-
hanced inherent ATPase activity (Prodromou et al.,1056 A˚2 of molecular surface. Although the Hsp90
N-terminal domain used in this study derives from yeast, 2000), but unlike Ala 107, Thr 22 is not involved in the
observed interface with p50cdc37. In this case, the ATPaseall the residues in contact with p50cdc37 are identical to
those in both of the human cytoplasmic Hsp90 isoforms, activity was fully sensitive to inhibition by p50cdc37, show-
ing that the desensitization produced by the A107N mu-with the exception of Ser 109 on the edge of the lid,
which hydrogen bonds to the side chain of p50cdc37 Lys tation is specific and not a general property of hyperac-
tive Hsp90 mutants. Consistent with its effect on ATPase202—an interaction available to the glutamine found at
this position in human Hsp90s. inhibition, and in contrast to wild-type, no significant
heat was generated when p50cdc37 was titrated intoWe have previously described a mutation engineered
in the surface of the lid segment, A107N, which activates Hsp90-A107N in ITC experiments (Figure 4D).
The side chain of Arg 167 from p50cdc37 points downthe inherent ATPase of Hsp90 probably by favoring lid
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Figure 2. Structure of C-p50cdc37
(A) Secondary structure cartoon of C-p50cdc37 “rainbow” colored from the visible N terminus at residue 148 (blue) to the visible C terminus at
347 (red). The disordered polypeptide chain connecting residues 308 and 316 is indicated by a dotted line.
(B) Alignment of the sequence and structure of human p50cdc37 with the amino acid sequences of representative p50cdc37 homologs from
amphibians (Xenopus laevis), fish (Tetraodon fluviatilis–pufferfish), insects (Drosophila melanogaster), and worms (Caenorhabditis elegans);
human Harc (Hsp90-associating relative of Cdc37- (Scholz et al., 2001) and Saccharomyces cerevisiae Cdc37p. Sequences in the region
delineated by the C-p50cdc37 structure described here are shown in bold-face type and the observed secondary structural elements are shown
above the sequence. The yeast Cdc37p sequence beyond residue 120 is extremely diverged with several substantial relative insertions and
cannot be aligned reliably. The alignment shown here is based on optimal sequence threading (Jones et al., 1992) of the Cdc37p sequence
on the C-p50cdc37 structure and may be more accurate than a purely sequence-based alignment, but should be regarded with suspicion. The
“zigzag” over the N-terminal protein kinase binding region of the p50cdc37 sequence indicates a predicted 70 residue coiled-coil segment.
Residues involved in C-p50cdc37 dimerization are highlighted in yellow; those involved in interaction with Hsp90 are highlighted in pink.
into the mouth of the nucleotide binding pocket in the is believed to act as the general base in the chaperone’s
ATPase reaction (Prodromou et al., 1997a; PanaretouHsp90 N-terminal domain and hydrogen bonds to the
carboxyl side chain of Glu 33 (Figure 5A). This residue et al., 1998; Obermann et al., 1998), and the guanidinium
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Figure 3. C-p50cdc37 Dimer
(A) Secondary structure cartoon of C-p50cdc37 dimer (one monomer is colored cyan, the other green).
(B) As (A) but rotated around the vertical.
(C) As (A) but rotated about the horizontal. The dimer is shown as molecular surfaces on the right. The C-p50cdc37 dimer exists in solution with
a Kd  170 M and dimer formation buries 560 A˚2 of molecular surface.
(D) Details of the interactions in the C-p50cdc37 dimer interface. Hydrogen bonds are indicated by broken rods connecting interacting atoms.
group of Arg 167 occupies the position expected for the namycin does not disrupt Hsp90-p50cdc37 complexes
(Shao et al., 2001). Nonetheless, the presence of the sideattacking nucleophilic water. Arg 167 does not penetrate
deeply enough into the pocket to obstruct binding of chain of Arg 167 does alter the electronic and chemical
environment at the top of the pocket, so that Hsp90nucleotides or drugs such as geldanamycin (Figure 5B).
This is consistent with previous experimental observa- inhibitors that impinge upon this part of the pocket could
be tailored to bind selectively to, or be selectively ex-tions that binding of p50cdc37 does not displace geldana-
mycin from Hsp90 (Siligardi et al., 2002) and that gelda- cluded from, Hsp90-p50cdc37 complexes.
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Figure 4. Hsp90-p50 Interaction
(A) Secondary structure cartoon of the N-Hsp90-
C-p50cdc37 complex (rainbow colored as in Fig-
ure 2A) superimposed on the molecular sur-
faces of the two proteins (C-p50cdc37 cyan,
N-Hsp90 gold).
(B) Details of the interactions between
N-Hsp90 (gold side chain carbons and labels)
and C-p50cdc37 (cyan side chain carbons and
labels). The interface primarily involves
Hsp90 residues exposed on the face of the lid
segment (residues 100–121) in free N-Hsp90
structures, and residues from the loop be-
tween the first two helices and the beginning
of the third helix, in the C-p50cdc37 structure.
Ala 107 (underlined) from Hsp90 is fully ex-
posed in free N-Hsp90 structures, and its mu-
tation to asparagine has previously been
shown to enhance the ATPase activity of
Hsp90 (Prodromou et al., 2000) by favoring
lid closure on ATP binding, and promoting
N-terminal association in the Hsp90 dimer. In
the complex Ala 107 is buried in the core
of the hydrophobic interface with C-p50cdc37,
which would be completely disrupted by the
presence of larger hydrophilic residues such
as asparagine.
(C) ATPase activity of wild-type and mutant
Hsp90s (see Experimental Procedures), in the
presence of increasing amounts of C-p50cdc37.
Compared to wild-type, the A107N mutant
Hsp90 is effectively resistant to ATPase ar-
rest by C-p50cdc37. A second hyperactive
Hsp90 mutant T22I retains full sensitivity to
C-p50cdc37.
(D) ITC of C-p50cdc37 binding to wild-type or
A107N Hsp90. While the wild-type chaperone
interacts with micromolar affinity, there is no
detectable binding to the A107N mutant, con-
sistent with the disruption of the interface this
mutation would cause.
Binding of p50cdc37 elicits some small but potentially polypeptide chain displays two alternative conforma-
tions in human Hsp90 N-terminal domain structuressignificant conformational changes in the N-terminal do-
main of Hsp90 compared to the structures of the free (Stebbins et al., 1997), however this helical conformation
observed in the presence of p50cdc37 is substantially dif-or nucleotide bound domain. The lid segment, which
provides the majority of the interaction with p50cdc37, ferent from either of those.
moves away from the rest of the domain, hinging at
glycines 100 and 121, with the tip of the lid moving by Architecture of the Hsp90-p50cdc37 Complex
Within the crystals the C-p50cdc37 dimer sits between twomore than 3 A˚ compared to the structures in the absence
of p50cdc37 (PDB codes 1AH6, 1AMW) (Figure 5C). Ac- symmetry related Hsp90 N-terminal domains, which are
orientated so that the open mouths of their nucleotidecompanying the lid movement, is a substantial restruc-
turing of the backbone between Leu 93 and Gly 100 binding pockets are facing each other, but 40A˚ apart.
The large globular domain of the C-p50cdc37 moleculeswhich takes on an -helical conformation, extending the
helix from 101–109 in the free structure by nearly two forming the dimer, and the two bound Hsp90 N-terminal
domains lie in a plane, with the long helix and smallturns at its N terminus and the helix from 86–92 by a turn
at its C terminus. This change in backbone conformation C-terminal helical bundle from each of the C-p50cdc37
molecules projecting 50 A˚ from one face of the planecauses substantial movement in the side chains of Ile
96, Ala 97, and particularly Lys 98 whose side chain (Figures 6A and 6B). Hsp90 functions as a dimer, with a
high-affinity constitutive dimerization interface provided-amino group is flipped by 12A˚ away from the ATP
binding pocket, where it interacts with the -phosphate by the C-terminal regions (Nemoto et al., 1995) and an
ATP-dependent interface involving the N-terminal do-of bound nucleotides (Prodromou et al., 1997a), and
out into the solvent (Figure 5D). This segment of the mains (Prodromou et al., 2000; Chadli et al., 2000; Weg-
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Figure 5. Pocket and Lid Interactions
(A) Model of ADP bound to N-Hsp90 in the presence of C-p50cdc37, generated by superimposing N-Hsp90 from the previously described
N-Hsp90-ADP complex (Prodromou et al., 1997a) onto the N-Hsp90 in this complex. Arg 167 of C-p50cdc37 inserts its side chain into the mouth
of the nucleotide binding pocket of Hsp90, hydrogen bonding with the carboxylate side chain of the catalytic residue Glu 33, and with its
guanidinium head group occupying the position expected for the attacking water in the ATPase reaction. The key adenine binding residue,
Asp 79, is indicated.
(B) Model of geldanamycin (GD) bound to N-Hsp90 in the presence of C-p50cdc37, generated by superimposing N-Hsp90 from the previously
described N-Hsp90-GD complex (Roe et al., 1999) onto the N-Hsp90 in this complex. Consistent with biochemical observations (Siligardi et
al., 2002; Shao et al., 2001) the presence of Arg 167 would not be expected to interfere with geldanamycin binding, however it would certainly
alter the chemical environment of the mouth of the pocket, and in vivo could selectively limit or enhance binding of larger Hsp90 inhibitors.
(C) Superimposition of N-Hsp90 structure in the p50cdc37 complex (gold C trace) on the N-Hsp90 structure from the ADP-complex. Binding
of C-p50cdc37 (cyan cartoon) lifts the lid away from the body of the structure, and causes a rearrangement of residues 96–99.
(D) As (C) but viewed toward the nucleotide binding pocket. Lifting of the lid imposes a helical conformation on residues 96–99, causing the
tip of the side chain of Lys 98 to move by 12 A˚.
ele et al., 2003). Hsp90 and p50cdc37 interact as dimers Taken together, all these data suggest that the complex
of the N-Hsp90 and C-p50cdc37 domains described herewith 1:1 molar stoichiometry, and part of the p50cdc37
dimerization interface is provided by the Hsp90 binding is a true representation of the interaction of these re-
gions of the two molecules within the full (Hsp90)2-C-terminal region of p50cdc37 present in the structure de-
scribed here (Siligardi et al., 2002). All the interactions (p50cdc37)2 heterotetramer complex.
In Hsp90, the N-terminal domain is followed by a mid-observed between Hsp90 and p50cdc37 and within the
p50cdc37 dimer are provided by the large globular domain dle segment, consisting of two  domains connected
by a short helical supercoil (Meyer et al., 2003), whichof the C-p50cdc37 structure, consistent with the observa-
tion in yeast Cdc37p that regions C-terminal to this are is directly implicated in interactions with several client
proteins, including protein kinases (Sato et al., 2000;dispensable for normal function in vivo (Lee et al., 2002).
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Figure 6. Architecture of the Hsp90-p50cdc37 Complex
(A) Secondary structure cartoon of the (N-Hsp90)2-(C-p50cdc37)2 complex. The crystal asymmetric unit contains one N-Hsp90-C-p50cdc37 hetero-
dimer, and the complete heterotetramer is formed by the homodimerization of two crystallographically related C-p50cdc37 molecules (cyan/
green). N-Hsp90 is shown in gold. The positions of the N terminus of C-p50cdc37 and the C terminus of N-Hsp90 are indicated.
(B) As (A) but viewed from the opposite side to the long helical protrusions of C-p50cdc37. The N termini of both C-p50cdc37 molecules and the
C termini of both N-Hsp90s are on this face.
(C) Hypothetical model of a complete Hsp90-p50cdc37-client protein kinase complex. The bottom of the structure is the observed (N-Hsp90)2-
(C-p50cdc37)2 heterotetramer, described here. The known crystal structure of the middle domain of Hsp90 (Meyer et al., 2003) has been positioned
so that its N terminus is within 8 A˚ of the C terminus of N-Hsp90. The structure of the C-terminal constitutive dimerization domain of Hsp90
has not yet been described and is represented by a pair of cylinders. Although the structure of the N-terminal domain of p50cdc37 is also
unknown, it predicts strongly as a substantial coiled-coil, and in this model is represented by a coiled-coil of comparable length, from seryl-
tRNA synthetase (PDB code 1SET), docked to connect with the N terminus of the observed C-p50cdc37. Finally, the structure of a known client
Structure of Hsp90-p50cdc37 Complex
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Fontana et al., 2002). From the position of the C terminus homologs. Secondly, p50cdc37 binds to the open face of
the lid segment in the N-domain of Hsp90, simultane-of the Hsp90 N-domain in the complex described here,
the middle and C-terminal segments in the intact Hsp90 ously preventing its closure over bound ATP and
blocking access by the middle segment that providesdimer would have to be on the opposite side of the plane
(see above) to the projecting helical segments of p50cdc37. the “missing” catalytic residue(s) needed to orientate
and polarize the -phosphate. Thirdly, the p50cdc37 dimerThe structure of the N-terminal kinase binding domain of
p50cdc37 is as yet unknown, although structure prediction sits between the two N-domains of the Hsp90 clamp,
holding them open like a brace and preventing theirsuggests it has a substantial coiled-coil content. From
a similar consideration of the position of the N terminus trans-activating interaction.
An ability to arrest the Hsp90 ATPase cycle is sharedof C-p50cdc37, whatever its structure the N-terminal do-
main is also likely to be directed in the opposite direction by p50cdc37 and Hop/Sti1 (Prodromou et al., 1999; Sili-
gardi et al., 2002), both of which are “early” cochaper-to the helical protrusions and in the same direction as
the middle segment of Hsp90, suggesting an overall ones involved in recruitment of client proteins to the
Hsp90 machinery. How Hop/Sti1 inhibits Hsp90 is nothead-to-tail interaction between Hsp90 and p50cdc37.
This arrangement would allow simultaneous interaction yet described. p50cdc37 holds Hsp90 in an “open” confor-
mation in which the putative binding surfaces in theof a client protein kinase with the middle segment of
Hsp90, and with the N-terminal domain of p50cdc37 (Fig- middle segment of the chaperone (Fontana et al., 2002;
Sato et al., 2000; Meyer et al., 2003) would be accessibleure 6C).
to a client protein kinase bound to the N-terminal domain
of p50cdc37. Progress from this arrested “loading” phaseMechanism of Hsp90 ATPase Arrest by p50cdc37
The combination of the constitutive C-terminal interface through the ATPase cycle would absolutely depend on
ejection of the p50cdc37 C terminus from between theand the ATP-dependent association of the N-terminal
domains generates a molecular clamp, whose opening jaws of the Hsp90 clamp to allow it to close. However,
p50cdc37 could remain persistently associated with theand closing is coupled to the ATPase activity of the
chaperone (Prodromou et al., 2000). Although it has not cycling Hsp90 complex via the interaction of its N termi-
nus with the bound client protein kinase. The rate withyet been observed directly, substantial evidence from
biochemical studies (Prodromou et al., 2000; Richter et which the arrested Hsp90-p50cdc37 complex converts to
a cycling complex will undoubtedly be affected by otheral., 2001, 2002) and analogy with related dimeric GHKL-
family ATPases (Dutta and Inouye, 2000) suggests that cochaperones such as Aha1, immunophilins, and p23/
Sba1, whose binding influences the Hsp90 ATPase cyclethe N-terminal domains in the Hsp90 dimer must come
into direct contact for ATP hydrolysis to take place. (Panaretou et al., 2002; Lotz et al., 2003; Young and
Hartl, 2000). However, it is also likely to depend on theDimerization of the N-terminal domains within the dimer
is believed to be driven by self-association of a hy- nature and affinity of the interaction of the client protein
itself with Hsp90, communicated via the N-terminal ki-drophobic surface, exposed when the lid segment
closes over bound ATP (Prodromou et al., 1997a, 2000), nase binding domain of p50cdc37 to its inhibitory C ter-
minus.and reinforced by interactions involving the first strand
of the N-domain (Richter et al., 2002). However, dimer-
Experimental Proceduresization of the N-terminal domains while necessary is not
sufficient, and the middle segment of Hsp90 from each
Expression and Purification of Proteinsmonomer must contribute additional catalytic resi-
Native and mutant yeast Hsp90 constructs, or human p50cdc37 con-
due(s), for ATP-hydrolysis to occur (Soti et al., 2002; structs, were inserted with N-terminal His6-tag into pRSETA and
Meyer et al., 2003). expressed in E. coli BL21(DE3) pLysS as previously described (Pro-
From the complex described here, it is evident that dromou et al., 2000; Siligardi et al., 2002; Meyer et al., 2003). In all
cases, expressed proteins were purified by metal affinity chroma-p50cdc37 achieves its inhibitory effect on the Hsp90 AT-
tography on Talon resin, ion-exchange on Q-Sepharose, and size-Pase cycle by interfering with several key points in the
exclusion chromatography on a Superdex 75 PG or Sephacryl 400chain of events that permits ATP-hydrolysis. Firstly,
HR column equilibrated in 20 mM Tris [pH 7.5], 150 mM NaCl, 1 mM
p50cdc37 chemically disables nucleophilic attack on the EDTA, and 0.5 mM DTT (buffer A). Fractions containing pure cleaved
- phosphoester bond of ATP by inserting the side proteins were dialyzed against buffer A and finally concentrated
chain of Arg 167 into the mouth of the nucleotide binding using 5K Vivaspin concentrators. Purified human Hsp90N-terminal
domain was a kind gift from Dr. Adam Collier, Vernalis, Cambridge,pocket, where it hydrogen bonds to and neutralizes the
United Kingdom.general base Glu 33, occupying the probable site of the
attacking water molecule. While this certainly contrib-
Isothermal Titration Calorimetry and ATPase Assaysutes to inhibition, it cannot be essential, as Arg 167 is
Heats of interaction between Hsp90 and p50cdc37 constructs werenot fully conserved, being lysine in flies, asparagine in
measured on a MSC system (Microcal Inc.). 15 aliquots of 20 l
worms, and isoleucine in yeast Cdc37p, which is none- C-p50cdc37 (250 M) were injected into 1.458 ml of 25 M Hsp90
theless able to inhibit Hsp90 ATPase activity (Siligardi construct at 30C in 40 mM Tris [pH 8.0] containing 1 mM EDTA
and 5 mM NaCl. For the full-length proteins, p50cdc37 was injectedet al., 2002), albeit with lower affinity than the mammalian
protein kinase, Cdk6 (PDB code 1BI7) (pink molecular surface) was docked between the two Hsp90 middle segments and the modeled p50cdc37
N-terminal coiled-coil, so as to minimize steric clashes while contacting residues from the middle segment implicated in interaction with client
proteins (Sato et al., 2000; Fontana et al., 2002; Meyer et al., 2003). While this model is certainly inaccurate in many aspects, it provides a
useful synthesis of a great deal of fragmentary data.
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